相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular mechanism of PPAR in the regulation of age-related inflammation
Jae Heun Chung et al.
AGEING RESEARCH REVIEWS (2008)
The I kappa B kinase - a bridge between inflammation and cancer
Michael Karin
CELL RESEARCH (2008)
Nuclear receptors, intestinal architecture and colon cancer: an intriguing link
I. D'Errico et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
NF-κB and cancer -: identifying targets and mechanisms
Willscott E. Naugler et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
Bing-Hua Jiang et al.
DRUG RESISTANCE UPDATES (2008)
Adult and fetal wound healing
Basil M. Hantash et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Peroxisome proliferator-activated receptor α regulates skin inflammation and humoral response in atopic dermatitis
Delphine Staumont-Salle et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
A gut feeling of the PXR, PPAR and NF-kappa B connection
W. Wahli
JOURNAL OF INTERNAL MEDICINE (2008)
Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology
Matthias Schmuth et al.
JOURNAL OF LIPID RESEARCH (2008)
Current status of COX-2 inhibitors
Palwinder Singh et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Lipid signalling in disease
Matthias P. Wymann et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Hepatic NF-κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis
F. Thomas Wunderlich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
Dipak Panigrahy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The opposing effects of n-3 and n-6 fatty acids
Gerd Schmitz et al.
PROGRESS IN LIPID RESEARCH (2008)
WITHDRAWN: Peroxisome proliferator- activated receptorγ Plo12Ala polymorphism influences the susceptibility of Japanese to gastric cancer
Tomomitsu Tahara et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
A Role for PPAR beta/delta in Tumor Stroma and Tumorigenesis
Rolfm Mueller et al.
PPAR RESEARCH (2008)
Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer
Dingzhi Wang et al.
PPAR RESEARCH (2008)
The Role of PPAR-gamma and Its Interaction with COX-2 in Pancreatic Cancer
Guido Eibl
PPAR RESEARCH (2008)
A Role for PPAR gamma in the Regulation of Cytokines in Immune Cells and Cancer
Xiao Yi Yang et al.
PPAR RESEARCH (2008)
PPAR gamma and MEK Interactions in Cancer
Elke Burgermeister et al.
PPAR RESEARCH (2008)
The Role of PPARs in Cancer
Keisuke Tachibana et al.
PPAR RESEARCH (2008)
Macrophages, PPARs, and Cancer
Jo A. Van Ginderachter et al.
PPAR RESEARCH (2008)
Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology
Jessica Wray et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription
Friedhelm Schroeder et al.
LIPIDS (2008)
Synergistic effects of RXRα and PPARγ ligands to inhibit growth in human colon cancer cells -: phosphorylated RXRα is a critical target for colon cancer management
Kenji Yamazaki et al.
GUT (2007)
5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model
Ikuko Ikeda et al.
CLINICAL CANCER RESEARCH (2007)
PPARβ/δ protects against experimental colitis through a ligand-independent mechanism
Holly E. Hollingshead et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
The nuclear hormone receptor peroxisome proliferator-activated receptor β/δ potentiates cell chemotactism, polarization, and migration
Nguan Soon Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Murine models of intestinal cancer: Recent advances
Paul Shaw et al.
DNA REPAIR (2007)
Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor γ
Yoshito Takeuchi et al.
CARCINOGENESIS (2007)
Safety issues and prospects for future generations of PPAR modulators
Anne Rubenstrunk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease
Liliane Michalik et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Absence of functional peroxisome proliferator-activated receptor-α enhanced ileum permeability during experimental colitis
Emanuela Mazzon et al.
SHOCK (2007)
PPARγ in human and mouse physiology
Sami Heikkinen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Modulation of PPAR activity via phosphorylation
Katherine A. Burns et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
W. Ahmed et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Fenofibrate represses interleukin-17 and interferon-γ expression and improves colitis in interleukin-10-deficient mice
Jimmy W. Lee et al.
GASTROENTEROLOGY (2007)
Thiazolidinediones in dermatology
Alan S. Boyd
INTERNATIONAL JOURNAL OF DERMATOLOGY (2007)
Rosiglitazone, a PPARγ ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats
Marina Sanchez-Hidalgo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors
Thaddeus T. Schug et al.
CELL (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
Enrico Flossmann et al.
LANCET (2007)
The PPARγ agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis
Julian D. Ramakers et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
The role of PPARγ on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction
Angel Ponferrada et al.
GASTROENTEROLOGY (2007)
A cytokine-mediated link between innate immunity, inflammation, and cancer
Wan-Wan Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Malignant transformation of DMBA/TPA-induced papillomas and Nevi in the skin of mice selectively lacking retinoid-X-receptor α in epidermal keratinocytes
Arup Kumar Indra et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth
Arja Kaipainen et al.
PLOS ONE (2007)
Variations in the peroxisome proliferator-activated receptor-γ gene and melanoma risk
Rotraut Moessner et al.
CANCER LETTERS (2007)
Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor γ
Elke Burgermeister et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Expression of peroxisome proliferator-activated receptor-γ in macrophage suppresses experimentally induced colitis
Yatrik M. Shah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs
R. N. Reddy et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Action of epoxyeicosatrienoic acids on cellular function
Arthur A. Spector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Tumour necrosis factor alpha blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis
X. Han et al.
GUT (2007)
Peroxisome proliferator-activated receptor gamma is required for regulatory CD4(+) T cell-mediated protection against colitis
Raquel Hontecillas et al.
JOURNAL OF IMMUNOLOGY (2007)
PPARs in Calorie Restricted and Genetically Long-Lived Mice
Michal M. Masternak et al.
PPAR RESEARCH (2007)
Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation
Asha Jacob et al.
PPAR RESEARCH (2007)
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
Liliane Michalik et al.
PHARMACOLOGICAL REVIEWS (2006)
PPARγ agonists prevent TGFβ1 Smad3-signaling in human hepatic stellate cells
Caiyan Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
A novel positive feedback loop between peroxisome proliferator-activated receptor-δ and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth
Lihong Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease
James Varani et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-γ- and ERK-dependent in human non-small lung cancer cells
Mingyue Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Peroxisome proliferator-activated receptor γ is highly expressed in pancreatic cancer and is associated with shorter overall survival times
Glen Kristiansen et al.
CLINICAL CANCER RESEARCH (2006)
ERK5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor δ (PPARδ) stimulation
Chang-Hoon Woo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Acetaldehyde inhibits PPARγ via H2O2-mediated c-Abl activation in human hepatic stellate cells
Elisabetta Ceni et al.
GASTROENTEROLOGY (2006)
Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor γ
Robert A. Winn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Peroxisomal proliferator-activated receptor-γ agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells
Aurora Aiello et al.
ENDOCRINOLOGY (2006)
Peroxisome proliferator-activated receptor γ promotes epithelial to mesenchymal transformation by rho GTPase-dependent activation of ERK1/2
Lu Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
PPARγ activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404
Wen Zhang et al.
CANCER BIOLOGY & THERAPY (2006)
Amelioration of age-related inflammation and oxidative stress by PPARγ activator:: Suppression of NF-κB by 2,4-thiazolidinedione
Bokyung Sung et al.
EXPERIMENTAL GERONTOLOGY (2006)
Peroxisome proliferator-activated receptors-γ activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis
HY Kang et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2006)
Peroxisome-proliferator-activated receptor ot agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1
R Grau et al.
BIOCHEMICAL JOURNAL (2006)
Transcriptional regulation of metabolism
B Desvergne et al.
PHYSIOLOGICAL REVIEWS (2006)
High-density lipoprotein hydrolysis by endothelial lipase activates PPARα -: A candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion
W Ahmed et al.
CIRCULATION RESEARCH (2006)
Involvement of PPAR nuclear receptors in tissue injury and wound repair
L Michalik et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
PPAR-γ agonist increase gefitinib's antitumor activity through PTEN expression
SY Lee et al.
LUNG CANCER (2006)
From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions
JN Feige et al.
PROGRESS IN LIPID RESEARCH (2006)
Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-γ, normalizes epidermal homeostasis in a murine hyperproliferative disease model
M Demerjian et al.
EXPERIMENTAL DERMATOLOGY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
CM Ulrich et al.
NATURE REVIEWS CANCER (2006)
Thiazolidinediones inhibit insulin-like growth factor-I-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity
GB He et al.
CANCER RESEARCH (2006)
Rosiglitazone suppresses human lung carcinoma cell growth through PPAR-γ-dependent and PPARγ-independent signal pathways
SW Han et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence
P. Desreumaux et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism
A Chmurzynska
JOURNAL OF APPLIED GENETICS (2006)
Peroxisome proliferator-activated receptor γ suppresses proximal α1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells
S Yavrom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) increases the expression of prostaglandin E2 receptor subtype EP4 -: The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein β
SW Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing
L Michalik et al.
MOLECULAR ENDOCRINOLOGY (2005)
The effect of PPAR ligands on UV-γ or chemically-induced carcinogenesis in mouse skin
GB He et al.
MOLECULAR CARCINOGENESIS (2005)
PPARγ as a therapeutic target for tumor angiogenesis and metastasis
D Panigrahy et al.
CANCER BIOLOGY & THERAPY (2005)
Cytokines and peroxisome proliferator-activated receptor γ ligand regulate phagocytosis by pancreatic stellate cells
K Shimizu et al.
GASTROENTEROLOGY (2005)
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands
H Kohno et al.
BMC CANCER (2005)
Genetic- or transforming growth factor-β1-induced changes in epidermal peroxisome proliferator-activated receptor β/δ expression dictate wound repair kinetics
NS Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Medical progress - Psoriasis
MP Schon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ
C Rousseaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Mechanisms of disease: inflammatory mediators and cancer prevention
JR Mann et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Peroxisome proliferator-activated receptor-β/δ inhibits epidermal cell proliferation by down-regulation of kinase activity
DJ Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice
DJ van Westerloo et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
PPAR-gamma modulates allergic inflammation through upregulation of PTEN
KS Lee et al.
FASEB JOURNAL (2005)
Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor β/δ during hair follicle development
N Di-Poï et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Adipogenic transcriptional regulation of hepatic stellate cells
HY She et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Epidermal peroxisome proliferator-activated receptor γ as a target for ultraviolet B radiation
QW Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PPAR gamma expression in breast cancer: clinical value and correlation with ER beta
I Papadaki et al.
HISTOPATHOLOGY (2005)
PPARs in diseases: Control mechanisms of inflammation
R Kostadinova et al.
CURRENT MEDICINAL CHEMISTRY (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein
S Cuzzocrea et al.
INTENSIVE CARE MEDICINE (2004)
Inhibition of melanoma metastases by fenofibrate
M Grabacka et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2004)
Peroxisome proliferator-activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells
S Hazra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Expression and function of peroxisome proliferator-activated receptors in human melanocytes
HY Kang et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer
VG Keshamouni et al.
ONCOGENE (2004)
Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ
DZ Wang et al.
CANCER CELL (2004)
PPARγ influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis
CJ Nicol et al.
CARCINOGENESIS (2004)
Protective effect of endogenous PPARγ against acute gastric mucosal lesions associated with ischemia-reperfusion
K Wada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Peroxisome-proliferator-activated receptors and cancers: Complex stories
L Michalik et al.
NATURE REVIEWS CANCER (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Fatty acid-binding proteins - insights from genetic manipulations
NH Haunerland et al.
PROGRESS IN LIPID RESEARCH (2004)
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats:: role of oxygen free radicals generation
I Villegas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities
CM Jenkins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase
R Zimmermann et al.
SCIENCE (2004)
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma
A Reichle et al.
CANCER (2004)
PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats
T Toyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids
JA Villena et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Essential role of Smad3 in the inhibition of inflammation-induced PPARβ/δ expression
NS Tan et al.
EMBO JOURNAL (2004)
Peroxisome proliferator-activated receptor β (δ)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis
DJ Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Implication of peroxisome proliferator-activated receptor γ and proinflammatory cytokines in gastric carcinogenesis:: Link to Helicobacter pylori-infection
PC Konturek et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPAR γ and apoptosis-related proteins in gastric cancer patients
PC Konturek et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?
G Gasparini et al.
LANCET ONCOLOGY (2003)
Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut
S Cuzzocrea et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Troglitazone antagonizes tumor necrosis factor-α-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-κB
H Ruan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Science, medicine, and the future - Cirrhosis: new research provides a basis for rational and targeted treatments
JP Iredale
BMJ-BRITISH MEDICAL JOURNAL (2003)
Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat
PC Konturek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Peroxisome proliferator-activated receptor α negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation
DC Jones et al.
JOURNAL OF IMMUNOLOGY (2003)
The PPARγ ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis
K Hashimoto et al.
PANCREAS (2003)
A novel PPARγ gene therapy to control inflammation associated with inflammatory bowel disease in a murine model
K Katayama et al.
GASTROENTEROLOGY (2003)
Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an anti inflammatory role for lipoprotein lipase
O Ziouzenkova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PPARγ is a very low-density lipoprotein sensor in macrophages
A Chawla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice
E Osawa et al.
GASTROENTEROLOGY (2003)
Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappa B in normal and lesional psoriatic skin
M Westergaard et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: Immunohistochemical analysis of 15 cases
P Mukunyadzi et al.
MODERN PATHOLOGY (2003)
Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells
K Hellemans et al.
GASTROENTEROLOGY (2003)
Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/reperfusion in rat
PC Konturek et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Effect of topical PPAR beta/6 and PPAR gamma agonists on plaque psoriasis - A pilot study
S Kuenzli et al.
DERMATOLOGY (2003)
Analysis of tissue-specific and PPAR-α-dependent induction of FABP gene expression in the mouse liver by an in vivo DNA electroporation method
K Fujishiro et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway
N Di-Poï et al.
MOLECULAR CELL (2002)
A case-control study of lung cancer in Casablanca, Morocco
AJ Sasco et al.
CANCER CAUSES & CONTROL (2002)
Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis
LJ Saubermann et al.
INFLAMMATORY BOWEL DISEASES (2002)
Agonists of peroxisome proliferator-activated receptor γ inhibit cell growth in malignant melanoma
R Mössner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription
NS Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by peroxisome proliferator-activated receptor γ activation
BL Slomiany et al.
IUBMB LIFE (2002)
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
A Galli et al.
GASTROENTEROLOGY (2002)
Lipases and HDL metabolism
WJ Jin et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and Nf-kB in human colon cancer
GG Chen et al.
LIFE SCIENCES (2002)
Ligands of peroxisome proliferator-activated receptor-γ block activation of pancreatic stellate cells
A Masamune et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis
K Shimizu et al.
PANCREAS (2002)
Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden
P Boffetta et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models
MY Sheu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats
Y Naito et al.
REDOX REPORT (2002)
A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats
H Ichikawa et al.
REDOX REPORT (2002)
Critical roles of PPARβ/δ in keratinocyte response to inflammation
NS Tan et al.
GENES & DEVELOPMENT (2001)
Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation
S Kippenberger et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor δ with head and neck squamous cell carcinoma
EC Jaeckel et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2001)
Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice
L Michalik et al.
JOURNAL OF CELL BIOLOGY (2001)
Differential involvement of peroxisome-proliferator-activated receptors α and δ in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine
H Poirier et al.
BIOCHEMICAL JOURNAL (2001)
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (BPARγ) heterodimer:: A basis for new therapeutic strategies
P Desreumaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
A Nakajima et al.
GASTROENTEROLOGY (2001)
Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer
RA Gupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Peroxisome proliferator-activated receptors and hepatic stellate cell activation
T Miyahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus
K Shimizu et al.
PANCREAS (2000)
Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells
F Marra et al.
GASTROENTEROLOGY (2000)
Troglitazone improves psoriasis and normalizes models of proliferative skin disease -: Ligands for peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation
CN Ellis et al.
ARCHIVES OF DERMATOLOGY (2000)
Stimulation of PPAR alpha promotes epidermal keratinocyte differentiation in vivo
LG Komuves et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
分享论文
